Moreover, CSPG4 displays a broad expression across several different cancer entities, such as melanoma [35], leukemia [36], glioma [37], triple-negative breast cancer [38], head and neck cancers [39], and mesenchymal cancers [40]. Here, CSPG4 is linked to triple-negative breast carcinoma.